Solid dosage form preparations from oily medicines and their drug release. Effect Of degree of surface-modification of silica gel on the drug release from phytonadione-loaded silica gels.
A surface-modified silica gel was produced to improve the surface affinity to an oily medicine, phytonadione (VK1). The effect of the degree of surface modification of the silica gel on the drug release behavior from the silica porous matrix was investigated. The silica gels were surface-modified using the silan coupling agent, 3-methacryloxypropyltrimethoxysilane (C7), octadecyltriethoxysilane (C18), or 3,3,3-trifluoropropyltrimethoxysilane (F3). A mixture of VK1 solution and surface-modified silica gel was evaporated under reduced pressure at room temperature, then the resulting powder was dried in vacuo. The degree of surface modification was evaluated based upon elementary analysis. The dissolution profiles of the samples were investigated in Japanese Pharmacopoeia XII, 1st fluid buffer (pH 1.2, 37+/-0.5 degrees C) containing 1.5% sodium lauryl sulfate. The FT-IR spectra of VK1-loaded surface-modified silica gels suggested that the amount of hydrogen-bonded VK1 with the silanol group on the gel surface decreased with increasing hydrophobicity of the silica gel. Since the modified group was rotating on the silica gel surface, and inhibited the adsorption of VK1 to the surface, the attractive molecular interaction between VK1 and the silica gel surface might decrease with increasing length of the modified functional group. However, the characteristics of the affinity of VK1 to the functional groups significantly differed among the groups. The VK1 release from the modified silica gels was initially rapid, slowed markedly after 1 h, and continued for more than 24 h. The amount of VK1 released from the modified surface silica gels by C7, C18 or F3 increased with increasing density of the surface modification group. The mean drug release moment (MDT) decreased with an increase in surface-modified group density.
Otsuka
M
M
Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Motoyama-Kitamachi, Higashi-Nada, 658, Kobe, Japan. m-otsuka@kobeharma-u.ac.jp
Tokumitsu
K
K
Matsuda
Y
Y
D000327:Adsorption; D000465:Algorithms; D000933:Antifibrinolytic Agents / Q000008:administration & dosage* / Q000737:chemistry; D003692:Delayed-Action Preparations; D006860:Hydrogen Bonding; D008855:Microscopy, Electron, Scanning; D009821:Oils / Q000008:administration & dosage*; D016062:Porosity; D011208:Powders; D020034:Silicone Gels / Q000737:chemistry*; D012995:Solubility; D017550:Spectroscopy, Fourier Transform Infrared; D013499:Surface Properties; D010837:Vitamin K 1 / Q000008:administration & dosage* / Q000737:chemistry
D000933:Antifibrinolytic Agents; D003692:Delayed-Action Preparations; D009821:Oils; D011208:Powders; D020034:Silicone Gels; D010837:Vitamin K 1